A high mutation rate of immunoglobulin heavy chain variable region gene associates with a poor survival and chemotherapy response of mantle cell lymphoma patients

Immunoglobulin heavy chain variable region (IGHV) gene mutation status is a biomarker for the prognosis of chronic lymphocytic leukemia, whether it is associated with the diagnosis, staging, and prognosis of patients with mantle cell lymphoma (MCL) remains to be determined. The IGHV gene mutations o...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xianqian, Wu, Ning, Li, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708879/
https://www.ncbi.nlm.nih.gov/pubmed/31145313
http://dx.doi.org/10.1097/MD.0000000000015811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708879/
https://www.ncbi.nlm.nih.gov/pubmed/31145313
http://dx.doi.org/10.1097/MD.0000000000015811

Ejemplares similares